Pfizer spends $11.4 billion to buy Array BioPharma for its cancer drug chemistry
Pfizer said it will spend $11.4 billion in cash to purchase Array BioPharma, a Boulder, Colo.-based biotech known as a top choice among biotechnology firms that need to synthesize new…
by Matthew Herper
Jun 17, 2019
2 minutes
Pfizer said Monday morning that it will spend $11.4 billion in cash to purchase Array BioPharma, a Boulder, Colo.-based biotech known not only for developing its own medicines but as being a top choice among biotechnology firms that need to synthesize new drugs. Pfizer said
You’re reading a preview, subscribe to read more.
Start your free 30 days